The FDA approval secures RevnaBio as the first biomedical company to register/deploy the NeuMoDx platform in Sub-Saharan Africa, hitherto mainly available in Europe, the Middle East, and North America Ghana-based […]
Polymerase Chain Reaction (PCR) has been a cornerstone technique in molecular biology for decades, enabling the amplification and detection of specific DNA sequences. Over time, advancements have improved the efficiency […]
Cancer is a global health challenge, affecting millions of lives every year. In recent years, advancements in molecular profiling have revolutionized our understanding of cancer biology and treatment strategies. In […]
Cancer is a formidable global health challenge, affecting millions of lives worldwide. In Ghana, the burden of cancer continues to rise, with limited access to advanced treatment options and high […]
Genomic research has emerged as a transformative field, revolutionizing our understanding of human health and genetics. In recent years, Ghana has positioned itself as a leading hub for genomic research […]
In the ever-evolving landscape of healthcare, precision medicine has emerged as a revolutionary approach to diagnosis, treatment, and management. In Ghana, Revna Biosciences has emerged as a trailblazer, establishing itself […]
Cancer is a global health challenge that affects millions of lives each year, and Ghana is no exception. With the increasing incidence of cancer cases in the country, the need […]
Revna Biosciences, a new precision medicine company, has unveiled a purpose-built, multifunctional biomedical research facility in Accra, Ghana. Infectious disease Revna’s goal is to increase access to advanced molecular diagnostics […]
Health Minister Kwaku Agyemang-Manu has lauded Revna Biosciences for advancing precision medicine to Africa through its base, established in Ghana. The Ministry of Health endorsed Revna Biosciences for the new […]